Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_assertion type Assertion NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_head.
- NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_assertion description "[sPLA2-IIA, a natural component of the immune system, may thus be considered a novel therapeutic agent to be used in adjunct with current therapy for treating anthrax.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_provenance.
- NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_assertion evidence source_evidence_literature NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_provenance.
- NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_assertion SIO_000772 16272335 NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_provenance.
- NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_assertion wasDerivedFrom befree-2016 NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_provenance.
- NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_assertion wasGeneratedBy ECO_0000203 NP521238.RAd3S5yxRZe_9Giir2oyiuEEwfzVlCFXC6Z3OZmqo0DBM130_provenance.